Clinical Trial Update: Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluates the efficacy and safety of Gadobutrol 1.0 Molar (Gadovist) for breast MRI; the study has completed and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gadovist (gadobutrol)

Snippet

Sponsor: Bayer | Conditions: Breast Cancer, Diagnostic Imaging | Phase 3 | Status: COMPLETED | Results posted: 2014-11-11